Useful Management Information

  • Women with a positive oncogenic HPV (16/18) test result or a (not 16/18) result and possible high-grade lesion should be referred directly for colposcopic assessment through the Gynaecology service. Similarly if the diagnosis is suspected or confirmed with initial tests, referral to a gynaecological oncologist (and subsequent multidisciplinary team assessment) is appropriate
  • Newly diagnosed women are discussed in a multidisciplinary team meeting and further investigations arranged appropriately. Issues regarding fertility, early menopause and changes to sexual function should be addressed
  • Depending on the stage of the malignancy treatment options may include surgery for small tumours found only within the cervix, radiation therapy concurrently with chemotherapy if it is anticipated that surgery will not remove all disease and in certain situations postoperative radiation therapy plus/minus chemotherapy may be recommended. For patients with metastatic disease chemotherapy and immunotherapy may be used as part of the treatment.
  • Serum tumour bio-markers such as CA15-3 or others should not be used as diagnostic tests
  • For women who have not completed their family, fertility preservation needs to be discussed and is often addressed as part of the Gynaecology-Oncology assessment
  • For patients with incurable (metastatic or recurrent) cancer consider the following:
    • documentation of discussions with the patient (and their carers where appropriate) regarding the intent of treatment (anti-cancer therapy to improve quality of life and/or longevity without expectation of cure or symptom palliation), the woman's prognosis and their understanding of their prognosis
    • whether Advance Care Planning (ACP) conversations have been undertaken and their outcome
    • specific patient goals and values that may impact on treatment choices
    • whether the patient has been referred to a palliative or supportive care service

Minimum Referral Criteria

Does your patient meet the minimum referral criteria?
Category 1 (appointment within 30 calendar days)
  • Patients with early stage or locally advanced Cervical cancer should be referred to the Gynaecology-Oncology surgical team for evaluation and further investigation / staging. Patients are usually then presented in a multi-disciplinary meeting for treatment planning and further referral if required for Medical Oncology input
  • Women with a positive oncogenic HPV (16/18) test result should be referred directly for colposcopic assessment, informed by the result of the reflex liquid-based cytology. Women with a positive oncogenic HPV (not 16/18) test result with a reflex liquid-based cytology result of possible high-grade lesion or high-grade lesion should be referred directly for colposcopic assessment through the Gynaecology team initially and then will be referred further to the Gynaecology-Oncology MDT as appropriate
  • Patients requiring chemotherapy and radiation for locally advanced disease (previously biopsy confirmed and discussed in Gynae-Oncology MDT) For optimum care, patient should be seen within 2 weeks
  • Patients requiring adjuvant chemotherapy (biopsy confirmed) For optimum care, patient should be seen within 2 weeks
  • Metastatic cervical cancer (biopsy confirmed
Category 2 (appointment within 90 calendar days)
  • Patients with previously treated locally advanced cervical cancer that required chemotherapy and require routine follow-up
  • Transfer of care from another health service
Category 3 (appointment within 365 calendar days)
  • No category 3 criteria

If your patient does not meet the minimum referral criteria

  • Assessment and management information may be found on a range of conditions at HealthPathways
  • If the patient does not meet the criteria for referral but the referring practitioner believes the patient requires specialist review, a clinical override may be requested:
    • Please explain why (e.g. warning signs or symptoms, clinical modifiers, uncertain about diagnosis, etc.)
  • Please note that your referral may not be accepted or may be redirected to another service

Essential Referral Information

  • Previous cancer treatment details including location; dates; treating doctor; details of prior treatment regimes and imaging / pathology results.
  • Previous screening test results
  • FBC results
  • ELFTs results
  • Histology /cytology results – current +/- previous
  • CT chest, abdomen and pelvis and MRI pelvis reports

Additional Referral Information

  • Other available imaging (e.g. PET imaging reports)
Last updated 19 February 2025

Send Referrals To

Smart Referrals

Preferred Method
About Smart Referrals

Secure Web Transfer

Not Available

Internal Referrals

Medical Oncology (E-Blueslips)

Fax

(07) 5687 4497

Post

Cancer Referral Centre,
Gold Coast University Hospital
1 Hospital Boulevard
Southport QLD 4215

Enquiries

(07) 5687 2708

Related HealthPathways

No directly related pathways found

Service Availability

Dr Marcin Dzienis
Medical Director Radiation Oncology (ICON Cancer Care)

Facilities

Gold Coast University Hospital

If you would like to send a named referral, please address it to the specialist listed above, who will allocate a suitably qualified specialist to see the patient. Alternatively, you can view a full list of our specialists.

Gold Coast Health - For Clinicians
© The State of Queensland 1995-2021 | Queensland Government
Queensland Government acknowledges the Traditional Owners of the land and pays respect to Elders past, present and future.